In the absence of the study by Mhawech-Fauceglia, the estimated pooled HR indicated that the high intraepithelial CD8+ TILs were still associated with improved PFS/DFS in ovarian cancer patients (Figure 3C; HR, 0.40; 95%CI, 0.29-0.55; PHR=0.001; I2=0.0%; fixed effects model). The gene discussed is CD8A; the disease is ovarian carcinoma.